Protein Kinase Inhibitors (Paperback). Dieser Artikel ist nicht verfügbar.
Sprache: Englisch
Verlag: Elsevier Science & Technology, Oxford, 2022
- Softcover
- Neu

Anbieter: AussieBookSeller, Truganina, VIC, AustralienAussieBookSeller
Verkäufer:in bei ZVAB seit 22. Juni 2007
Zustand: Neu
EUR 340,87
Artikelbeschreibung des Verkäufers
Paperback. Protein Kinase Inhibitors: From Discovery to Therapeutics Shipping may be from our Sydney, NSW warehouse or from our UK or US warehouse, depending on stock availability.
Bestandsnummer des Verkäufers 9780323912877
- Titel
- Protein Kinase Inhibitors (Paperback)
- Autor
- Md. Imtaiyaz Hassan
- Verlag
- Elsevier Science & Technology, Oxford
- Erscheinungsjahr
- 2022
- Zustand
- new
- Einband
- Paperback
- Sprache
- Englisch
- ISBN-10
- 0323912877
- ISBN-13
- 9780323912877
Protein Kinase Inhibitors: From Discovery to Therapeutics offers a foundational, pragmatic overview of protein kinases inhibitors and their potential role in disease modulation and treatment. Here, international experts in the field offer an integrated discussion of kinase inhibitor biology, biomarker discovery, and methods for drug design and development. After a brief overview of kinases and kinase inhibitors, subsequent chapters discuss individual kinases that are representative of the wider kinases and kinase families, including their roles in disease pathogenesis, underlying mechanisms, potential inhibitors and their modes of action for therapeutic modulation.
Several potential drugs under different stages of clinical trials are discussed, including their relevance to cancer, diabetes, obesity, cardiovascular, neurological, and auto-immune and inflammatory disease, among other disorders. The book also addresses the challenges and opportunities for future kinase inhibitor development.
„Inhaltsangabe“ gehört möglicherweise zu einer anderen Auflage dieses Titels.
Über die Autorin bzw. den Autor
Dr. Saba Noor is a Research Associate at the Centre for Interdisciplinary Research in Basic Sciences, Jamia Millia Islamia, New Delhi, India. Dr. Noor has expertise in molecular oncology, and her current research interests lie in development of kinase inhibitors for use in cancer therapeutics. She has published in such peer reviewed journals as Frontiers in Microbiology and International Journal of Biological Macromolecules, among other journals.
„Über diesen Titel“ gehört möglicherweise zu einer anderen Auflage dieses Titels.